These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38314348)

  • 1. Analyzing the ER stress response in ALS patient derived motor neurons identifies druggable neuroprotective targets.
    Watts ME; Giadone RM; Ordureau A; Holton KM; Harper JW; Rubin LL
    Front Cell Neurosci; 2023; 17():1327361. PubMed ID: 38314348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics.
    Watts ME; Wu C; Rubin LL
    J Exp Neurosci; 2019; 13():1179069519862798. PubMed ID: 31320806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.
    Wu C; Watts ME; Rubin LL
    Cell Rep; 2019 Jan; 26(5):1143-1156.e5. PubMed ID: 30699345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
    Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
    Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration.
    Tung YT; Peng KC; Chen YC; Yen YP; Chang M; Thams S; Chen JA
    Cell Stem Cell; 2019 Aug; 25(2):193-209.e7. PubMed ID: 31155482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Insights of Astrocyte-Mediated Hyperactive Autophagy and Loss of Motor Neuron Function in SOD1
    Rajpurohit CS; Kumar V; Cheffer A; Oliveira D; Ulrich H; Okamoto OK; Zatz M; Ansari UA; Khanna VK; Pant AB
    Mol Neurobiol; 2020 Oct; 57(10):4117-4133. PubMed ID: 32676988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients.
    Nakamura R; Tohnai G; Nakatochi M; Atsuta N; Watanabe H; Ito D; Katsuno M; Hirakawa A; Izumi Y; Morita M; Hirayama T; Kano O; Kanai K; Hattori N; Taniguchi A; Suzuki N; Aoki M; Iwata I; Yabe I; Shibuya K; Kuwabara S; Oda M; Hashimoto R; Aiba I; Ishihara T; Onodera O; Yamashita T; Abe K; Mizoguchi K; Shimizu T; Ikeda Y; Yokota T; Hasegawa K; Tanaka F; Nakashima K; Kaji R; Niwa JI; Doyu M; Terao C; Ikegawa S; Fujimori K; Nakamura S; Ozawa F; Morimoto S; Onodera K; Ito T; Okada Y; Okano H; Sobue G;
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):816-824. PubMed ID: 37142397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.
    Jin M; Akgün K; Ziemssen T; Kipp M; Günther R; Hermann A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.
    Hoye ML; Koval ED; Wegener AJ; Hyman TS; Yang C; O'Brien DR; Miller RL; Cole T; Schoch KM; Shen T; Kunikata T; Richard JP; Gutmann DH; Maragakis NJ; Kordasiewicz HB; Dougherty JD; Miller TM
    J Neurosci; 2017 May; 37(22):5574-5586. PubMed ID: 28416596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells.
    Li Q; Feng Y; Xue Y; Zhan X; Fu Y; Gui G; Zhou W; Richard JP; Taga A; Li P; Mao X; Maragakis NJ; Ying M
    Mol Neurodegener; 2022 Jan; 17(1):8. PubMed ID: 35012575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis.
    Kim BW; Ryu J; Jeong YE; Kim J; Martin LJ
    Front Cell Neurosci; 2020; 14():604171. PubMed ID: 33328898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous treatment for ALS with implication for broad neuroprotection.
    Kim D; Kim S; Sung A; Patel N; Wong N; Conboy MJ; Conboy IM
    Transl Neurodegener; 2022 Mar; 11(1):16. PubMed ID: 35272709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles.
    Le Gall L; Duddy WJ; Martinat C; Mariot V; Connolly O; Milla V; Anakor E; Ouandaogo ZG; Millecamps S; Lainé J; Vijayakumar UG; Knoblach S; Raoul C; Lucas O; Loeffler JP; Bede P; Behin A; Blasco H; Bruneteau G; Del Mar Amador M; Devos D; Henriques A; Hesters A; Lacomblez L; Laforet P; Langlet T; Leblanc P; Le Forestier N; Maisonobe T; Meininger V; Robelin L; Salachas F; Stojkovic T; Querin G; Dumonceaux J; Butler Browne G; González De Aguilar JL; Duguez S; Pradat PF
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1385-1402. PubMed ID: 35194965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo.
    Qian K; Huang H; Peterson A; Hu B; Maragakis NJ; Ming GL; Chen H; Zhang SC
    Stem Cell Reports; 2017 Apr; 8(4):843-855. PubMed ID: 28366455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.
    Hall CE; Yao Z; Choi M; Tyzack GE; Serio A; Luisier R; Harley J; Preza E; Arber C; Crisp SJ; Watson PMD; Kullmann DM; Abramov AY; Wray S; Burley R; Loh SHY; Martins LM; Stevens MM; Luscombe NM; Sibley CR; Lakatos A; Ule J; Gandhi S; Patani R
    Cell Rep; 2017 May; 19(9):1739-1749. PubMed ID: 28564594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.